FindTrial
Sign In

Efficacy and safety of dexmedetomidine combined with midazolam for sedation in pediatric patients

Efficacy and safety of dexmedetomidine combined with midazolam for sedation in pediatric patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067578
Enrollment
Unknown
Registered
2023-01-12
Start date
2023-01-12
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sedation in pediatric patients

Interventions

infant group:none
child group(1-6year old):none
school age group(>6year old):none

Sponsors

Department of anesthesiology, The Children's Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 10 Years

Inclusion criteria

Inclusion criteria: (1) Children sedated by dexmedetomidine combined with midazolam before examination; (2) No history of severe upper respiratory tract obstruction; (3) The families of the children signed informed consent. (4) There were no relative contraindications for sedation, such as nasal mucosa injury, severe upper respiratory tract infection, allergic history of sedation drugs, or mental or conscious disorders

Exclusion criteria

Exclusion criteria: (1) Dexmedetomidine combined with midazolam was not used; (2) Data lost

Design outcomes

Primary

MeasureTime frame
success rate;Sedation time;—

Secondary

MeasureTime frame
Sleep Latency;delayed recovery;—

Countries

China

Contacts

Public ContactJialian Zhao

The Children's Hospital, School of Medicine, Zhejiang University

zhaojl0510@zju.edu.cn18768117245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026